Status:
COMPLETED
Antioxidant Effects of Melatonin in Preterm
Lead Sponsor:
Azienda Ospedaliera Universitaria Policlinico "G. Martino"
Conditions:
Newborn Morbidity
Oxidative Stress
Eligibility:
All Genders
1-6 years
Phase:
NA
Brief Summary
Preterm infants are at risk of free radical mediated diseases from oxidative stress (OS) injury. Melatonin (MEL) is a powerful antioxidant and scavenger of free radicals. In preterm neonates, melatoni...
Eligibility Criteria
Inclusion
- Gestational age \<37 weeks
- Normal liver function tests
- Normal kidney function tests
Exclusion
- All babies not born in the clinic
- All babies with severe congenital malformations
- Sepsis
- Inborn errors of metabolism
- Babies suffering from perinatal asphyxia
- Babies born from mothers with mental disorders
- Sample hemolysis
- Insufficient sample
- withdraw informed consent.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04785183
Start Date
January 1 2019
End Date
September 1 2020
Last Update
March 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eloisa Gitto
Messina, Italy